| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
|
Hasegawa, Hirotaka
|
|
|
25 |
3 |
p. 619-628
|
article
|
| 2 |
A rare gastric lesion: diminutive, well-differentiated, Grade 3, type 3 gastric neuroendocrine tumor with extremely high ki-67 index removed en bloc under endoscopy
|
Zhu, Chunpeng
|
|
|
25 |
3 |
p. 659-664
|
article
|
| 3 |
Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma
|
Holmberg, Dag
|
|
|
25 |
3 |
p. 652-658
|
article
|
| 4 |
Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial
|
Jeffers, Michael
|
|
|
25 |
3 |
p. 598-608
|
article
|
| 5 |
CAF promotes chemoresistance through NRP2 in gastric cancer
|
Yang, Yanpeng
|
|
|
25 |
3 |
p. 503-514
|
article
|
| 6 |
Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast
|
Nakamura, Yusuke
|
|
|
25 |
3 |
p. 515-526
|
article
|
| 7 |
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer
|
Agnes, Annamaria
|
|
|
25 |
3 |
p. 629-639
|
article
|
| 8 |
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)
|
Shitara, Kohei
|
|
|
25 |
3 |
p. 586-597
|
article
|
| 9 |
Gastric cancer exosomes contribute to the field cancerization of gastric epithelial cells surrounding gastric cancer
|
Yoon, Jung Hwan
|
|
|
25 |
3 |
p. 490-502
|
article
|
| 10 |
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer
|
Fu, Lingfeng
|
|
|
25 |
3 |
p. 542-557
|
article
|
| 11 |
LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathway
|
He, Lingnan
|
|
|
25 |
3 |
p. 527-541
|
article
|
| 12 |
Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells
|
Umeda, Shinichi
|
|
|
25 |
3 |
p. 558-572
|
article
|
| 13 |
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)
|
Kim, Bum Jun
|
|
|
25 |
3 |
p. 609-618
|
article
|
| 14 |
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
|
Biesma, Hedde D.
|
|
|
25 |
3 |
p. 640-651
|
article
|
| 15 |
Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study
|
Takahashi, Yu
|
|
|
25 |
3 |
p. 481-489
|
article
|
| 16 |
rs2671655 single nucleotide polymorphism modulates the risk for gastric cancer in Helicobacter pylori–infected individuals: a genome-wide association study in the Korean population
|
Shin, Cheol Min
|
|
|
25 |
3 |
p. 573-585
|
article
|
Journal description